메뉴 건너뛰기




Volumn 26, Issue 7, 2015, Pages 1597-1607

Inflammation-induced IL-6 functions as a natural brake on macrophages and limits GN

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 130; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ALPHA; KI 67 ANTIGEN; MANNOSE RECEPTOR;

EID: 84924580495     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014060620     Document Type: Article
Times cited : (72)

References (62)
  • 1
    • 79957673711 scopus 로고    scopus 로고
    • IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
    • Neurath MF, Finotto S: IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 22: 83-89, 2011
    • (2011) Cytokine Growth Factor Rev , vol.22 , pp. 83-89
    • Neurath, M.F.1    Finotto, S.2
  • 2
    • 17644368573 scopus 로고    scopus 로고
    • Interleukin-6: Frombasic science to medicine-40 years in immunology
    • Kishimoto T: Interleukin-6: Frombasic science to medicine-40 years in immunology. Annu Rev Immunol 23: 1-21, 2005
    • (2005) Annu Rev Immunol , vol.23 , pp. 1-21
    • Kishimoto, T.1
  • 4
    • 0030890718 scopus 로고    scopus 로고
    • Gp130 and the interleukin-6 family of cytokines
    • Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15: 797-819, 1997
    • (1997) Annu Rev Immunol , vol.15 , pp. 797-819
    • Taga, T.1    Kishimoto, T.2
  • 5
    • 1642578987 scopus 로고    scopus 로고
    • IL-6 trans-signaling: The heat is on
    • Rose-John S, NeurathMF: IL-6 trans-signaling: The heat is on. Immunity 20: 2-4, 2004
    • (2004) Immunity , vol.20 , pp. 2-4
    • Rose-John, S.1    Neurath, M.F.2
  • 6
    • 33748848714 scopus 로고    scopus 로고
    • Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer
    • Rose-John S, Scheller J, Elson G, Jones SA: Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer. J Leukoc Biol 80: 227-236, 2006
    • (2006) J Leukoc Biol , vol.80 , pp. 227-236
    • Rose-John, S.1    Scheller, J.2    Elson, G.3    Jones, S.A.4
  • 7
    • 80052358980 scopus 로고    scopus 로고
    • Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
    • Jones SA, Scheller J, Rose-John S: Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121: 3375-3383, 2011
    • (2011) J Clin Invest , vol.121 , pp. 3375-3383
    • Jones, S.A.1    Scheller, J.2    Rose-John, S.3
  • 9
    • 33646577466 scopus 로고    scopus 로고
    • Reciprocal developmental pathways for the generation of pathogenic effectorTH17andregulatoryTcells
    • Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effectorTH17andregulatoryTcells.Nature 441: 235-238, 2006
    • (2006) Nature , vol.441 , pp. 235-238
    • Bettelli, E.1    Carrier, Y.2    Gao, W.3    Korn, T.4    Strom, T.B.5    Oukka, M.6    Weiner, H.L.7    Kuchroo, V.K.8
  • 12
    • 32244442562 scopus 로고    scopus 로고
    • TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
    • VeldhoenM, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189, 2006
    • (2006) Immunity , vol.24 , pp. 179-189
    • Veldhoen, M.1    Hocking, R.J.2    Atkins, C.J.3    Locksley, R.M.4    Stockinger, B.5
  • 14
    • 0034193039 scopus 로고    scopus 로고
    • IL-6 is required for the development of Th1 cell-mediated murine colitis
    • Yamamoto M, Yoshizaki K, Kishimoto T, Ito H: IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164: 4878-4882, 2000
    • (2000) J Immunol , vol.164 , pp. 4878-4882
    • Yamamoto, M.1    Yoshizaki, K.2    Kishimoto, T.3    Ito, H.4
  • 16
    • 81755184476 scopus 로고    scopus 로고
    • Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
    • Tanaka T, Narazaki M, Kishimoto T: Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases. FEBS Lett 585: 3699-3709, 2011
    • (2011) FEBS Lett , vol.585 , pp. 3699-3709
    • Tanaka, T.1    Narazaki, M.2    Kishimoto, T.3
  • 18
    • 84896495791 scopus 로고    scopus 로고
    • A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
    • Tanaka T, Narazaki M, Ogata A, Kishimoto T: A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Semin Immunol 26: 88-96, 2014
    • (2014) Semin Immunol , vol.26 , pp. 88-96
    • Tanaka, T.1    Narazaki, M.2    Ogata, A.3    Kishimoto, T.4
  • 19
    • 0024404853 scopus 로고
    • IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice
    • Aderka D, Le JM, Vilcek J: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143: 3517-3523, 1989
    • (1989) J Immunol , vol.143 , pp. 3517-3523
    • Aderka, D.1    Le, J.M.2    Vilcek, J.3
  • 20
    • 0025805971 scopus 로고
    • Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation
    • Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J: Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 138: 1097-1101, 1991
    • (1991) Am J Pathol , vol.138 , pp. 1097-1101
    • Ulich, T.R.1    Yin, S.2    Guo, K.3    Yi, E.S.4    Remick, D.5    Del Castillo, J.6
  • 21
    • 0025802831 scopus 로고
    • Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6
    • Ulich TR, Guo KZ, Remick D, del Castillo J, Yin SM: Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J Immunol 146: 2316-2323, 1991
    • (1991) J Immunol , vol.146 , pp. 2316-2323
    • Ulich, T.R.1    Guo, K.Z.2    Remick, D.3    Del Castillo, J.4    Yin, S.M.5
  • 22
    • 0032518415 scopus 로고    scopus 로고
    • IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
    • Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101: 311-320, 1998
    • (1998) J Clin Invest , vol.101 , pp. 311-320
    • Xing, Z.1    Gauldie, J.2    Cox, G.3    Baumann, H.4    Jordana, M.5    Lei, X.F.6    Achong, M.K.7
  • 23
    • 0026667576 scopus 로고
    • Inhibitory role of interleukin-6 in macrophage proliferation
    • Riedy MC, Stewart CC: Inhibitory role of interleukin-6 in macrophage proliferation. J Leukoc Biol 52: 125-127, 1992
    • (1992) J Leukoc Biol , vol.52 , pp. 125-127
    • Riedy, M.C.1    Stewart, C.C.2
  • 24
    • 0028031990 scopus 로고
    • Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55
    • Tilg H, Trehu E, Atkins MB, Dinarello CA,Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83: 113-118, 1994
    • (1994) Blood , vol.83 , pp. 113-118
    • Tilg, H.1    Trehu, E.2    Atkins, M.B.3    Dinarello, C.A.4    Mier, J.W.5
  • 25
    • 0033802096 scopus 로고    scopus 로고
    • Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophagelineage hemopoietic progenitor cells
    • Clutterbuck R, Powles R, Millar J, Catovsky D: Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophagelineage hemopoietic progenitor cells. Exp Hematol 28: 1120-1128, 2000
    • (2000) Exp Hematol , vol.28 , pp. 1120-1128
    • Clutterbuck, R.1    Powles, R.2    Millar, J.3    Catovsky, D.4
  • 28
    • 84857851446 scopus 로고    scopus 로고
    • Psoriasis onset with tocilizumab treatment for rheumatoid arthritis
    • Wendling D, Letho-Gyselinck H, Guillot X, Prati C: Psoriasis onset with tocilizumab treatment for rheumatoid arthritis. J Rheumatol 39: 657, 2012
    • (2012) J Rheumatol , vol.39 , pp. 657
    • Wendling, D.1    Letho-Gyselinck, H.2    Guillot, X.3    Prati, C.4
  • 29
    • 84879820208 scopus 로고    scopus 로고
    • Tocilizumabinduced immune complex glomerulonephritis in a patient with rheumatoid arthritis
    • Matsuo Y, Mizoguchi F, Kohsaka H, Ito E, Eishi Y, Miyasaka N: Tocilizumabinduced immune complex glomerulonephritis in a patient with rheumatoid arthritis. Rheumatology (Oxford) 52: 1341-1343, 2013
    • (2013) Rheumatology (Oxford) , vol.52 , pp. 1341-1343
    • Matsuo, Y.1    Mizoguchi, F.2    Kohsaka, H.3    Ito, E.4    Eishi, Y.5    Miyasaka, N.6
  • 30
    • 0027631201 scopus 로고
    • Interleukin-6 receptor blockage ameliorates murine lupus nephritis
    • Kiberd BA: Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol 4: 58-61, 1993
    • (1993) J Am Soc Nephrol , vol.4 , pp. 58-61
    • Kiberd, B.A.1
  • 31
    • 73649123508 scopus 로고    scopus 로고
    • Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: The IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus
    • Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A: Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: The IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol 37: 60-70, 2010
    • (2010) J Rheumatol , vol.37 , pp. 60-70
    • Cash, H.1    Relle, M.2    Menke, J.3    Brochhausen, C.4    Jones, S.A.5    Topley, N.6    Galle, P.R.7    Schwarting, A.8
  • 33
    • 0031861643 scopus 로고    scopus 로고
    • IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/WF1 mice
    • Mihara M, Takagi N, Takeda Y, Ohsugi Y: IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/WF1 mice. Clin Exp Immunol 112: 397-402, 1998
    • (1998) Clin Exp Immunol , vol.112 , pp. 397-402
    • Mihara, M.1    Takagi, N.2    Takeda, Y.3    Ohsugi, Y.4
  • 34
    • 33750011260 scopus 로고    scopus 로고
    • Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus
    • Liang B,Gardner DB,Griswold DE, Bugelski PJ, Song XY: Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology 119: 296-305, 2006
    • (2006) Immunology , vol.119 , pp. 296-305
    • Liang, B.1    Gardner, D.B.2    Griswold, D.E.3    Bugelski, P.J.4    Song, X.Y.5
  • 35
    • 0030699416 scopus 로고    scopus 로고
    • Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6
    • Karkar AM, Smith J, Tam FW, Pusey CD, Rees AJ: Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6. Kidney Int 52: 1313-1320, 1997
    • (1997) Kidney Int , vol.52 , pp. 1313-1320
    • Karkar, A.M.1    Smith, J.2    Tam, F.W.3    Pusey, C.D.4    Rees, A.J.5
  • 36
    • 0027491179 scopus 로고
    • Modulation of antibody-mediated glomerular injury in vivo by interleukin-6
    • Karkar AM, Tam FW, Proudfoot AE, Meager A, Rees AJ: Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. Kidney Int 44: 967-973, 1993
    • (1993) Kidney Int , vol.44 , pp. 967-973
    • Karkar, A.M.1    Tam, F.W.2    Proudfoot, A.E.3    Meager, A.4    Rees, A.J.5
  • 37
    • 0030934956 scopus 로고    scopus 로고
    • Antibody independent crescentic glomerulonephritis inmuchaindeficient mice
    • Li S, Holdsworth SR, Tipping PG: Antibody independent crescentic glomerulonephritis inmuchaindeficient mice. Kidney Int 51:672-678, 1997
    • (1997) Kidney Int , vol.51 , pp. 672-678
    • Li, S.1    Holdsworth, S.R.2    Tipping, P.G.3
  • 38
    • 2642707490 scopus 로고    scopus 로고
    • Crescentic glomerulonephritis in CD4-and CD8-deficient mice. Requirement for CD4 but not CD8 cells
    • Tipping PG, Huang XR, Qi M, Van GY, Tang WW: Crescentic glomerulonephritis in CD4-and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol 152: 1541-1548, 1998
    • (1998) Am J Pathol , vol.152 , pp. 1541-1548
    • Tipping, P.G.1    Huang, X.R.2    Qi, M.3    Van, G.Y.4    Tang, W.W.5
  • 44
    • 74049092328 scopus 로고    scopus 로고
    • Interleukin-6 release fromperipheralmononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis
    • Esposito P, BallettaMM, Procino A, Postiglione L,Memoli B: Interleukin-6 release fromperipheralmononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. Lupus 18: 1329-1330, 2009
    • (2009) Lupus , vol.18 , pp. 1329-1330
    • Esposito, P.1    Balletta, M.M.2    Procino, A.3    Postiglione, L.4    Memoli, B.5
  • 46
    • 80053159298 scopus 로고    scopus 로고
    • Complete remission of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis complicated with rheumatoid arthritis using a humanized anti-interleukin 6 receptor antibody
    • Sumida K, Ubara Y, Suwabe T, Hayami N, Hiramatsu R, Hasegawa E, Yamanouchi M, Hoshino J, Sawa N, Takemoto F, Takaichi K, Ohashi K: Complete remission of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis complicated with rheumatoid arthritis using a humanized anti-interleukin 6 receptor antibody. Rheumatology (Oxford) 50: 1928-1930, 2011
    • (2011) Rheumatology (Oxford) , vol.50 , pp. 1928-1930
    • Sumida, K.1    Ubara, Y.2    Suwabe, T.3    Hayami, N.4    Hiramatsu, R.5    Hasegawa, E.6    Yamanouchi, M.7    Hoshino, J.8    Sawa, N.9    Takemoto, F.10    Takaichi, K.11    Ohashi, K.12
  • 47
    • 75749113331 scopus 로고    scopus 로고
    • Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase i dosage-escalation study
    • Illei GG, Shirota Y, Yarboro CH, Daruwalla J, Tackey E, Takada K, Fleisher T, Balow JE, Lipsky PE: Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum 62: 542-552, 2010
    • (2010) Arthritis Rheum , vol.62 , pp. 542-552
    • Illei, G.G.1    Shirota, Y.2    Yarboro, C.H.3    Daruwalla, J.4    Tackey, E.5    Takada, K.6    Fleisher, T.7    Balow, J.E.8    Lipsky, P.E.9
  • 50
    • 79551668389 scopus 로고    scopus 로고
    • The emergence of TH17 cells as effectors of renal injury
    • Kitching AR, Holdsworth SR: The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol 22: 235-238, 2011
    • (2011) J Am Soc Nephrol , vol.22 , pp. 235-238
    • Kitching, A.R.1    Holdsworth, S.R.2
  • 51
    • 70349448417 scopus 로고    scopus 로고
    • Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation
    • Marks BR,NowyhedHN,Choi JY, Poholek AC,Odegard JM, Flavell RA, Craft J: Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol 10: 1125-1132, 2009
    • (2009) Nat Immunol , vol.10 , pp. 1125-1132
    • Marks, B.R.1    Nowyhed, H.N.2    Choi, J.Y.3    Poholek, A.C.4    Odegard, J.M.5    Flavell, R.A.6    Craft, J.7
  • 52
    • 73349132687 scopus 로고    scopus 로고
    • Natural occurring IL-17 producing T cells regulate the initial phase of neutrophilmediated airway responses
    • Tanaka S, Yoshimoto T, Naka T, Nakae S, Iwakura Y, Cua D, Kubo M: Natural occurring IL-17 producing T cells regulate the initial phase of neutrophilmediated airway responses. J Immunol 183: 7523-7530, 2009
    • (2009) J Immunol , vol.183 , pp. 7523-7530
    • Tanaka, S.1    Yoshimoto, T.2    Naka, T.3    Nakae, S.4    Iwakura, Y.5    Cua, D.6    Kubo, M.7
  • 53
    • 34547514211 scopus 로고    scopus 로고
    • IL-6-dependent and-independent pathways in the development of interleukin 17-producing T helper cells
    • Kimura A, Naka T, Kishimoto T: IL-6-dependent and-independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci U S A 104: 12099-12104, 2007
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 12099-12104
    • Kimura, A.1    Naka, T.2    Kishimoto, T.3
  • 54
    • 84857411475 scopus 로고    scopus 로고
    • Hitting a complex target: An update on interleukin-6 trans-signalling
    • Waetzig GH, Rose-John S: Hitting a complex target: An update on interleukin-6 trans-signalling. Expert Opin Ther Targets 16: 225-236, 2012
    • (2012) Expert Opin Ther Targets , vol.16 , pp. 225-236
    • Waetzig, G.H.1    Rose-John, S.2
  • 56
    • 0031025673 scopus 로고    scopus 로고
    • The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines
    • Taga T: The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. AnnMed 29: 63-72, 1997
    • (1997) AnnMed , vol.29 , pp. 63-72
    • Taga, T.1
  • 57
    • 84883832799 scopus 로고
    • A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis
    • Cochrane CG, Unanue ER, Dixon FJ: A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J Exp Med 122: 99-116, 1965
    • (1965) J Exp Med , vol.122 , pp. 99-116
    • Cochrane, C.G.1    Unanue, E.R.2    Dixon, F.J.3
  • 58
    • 80054728443 scopus 로고    scopus 로고
    • Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis
    • Anders HJ, Ryu M: Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80: 915-925, 2011
    • (2011) Kidney Int , vol.80 , pp. 915-925
    • Anders, H.J.1    Ryu, M.2
  • 62
    • 84877032979 scopus 로고    scopus 로고
    • Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis
    • Kluger MA, Zahner G, Paust HJ, Schaper M, Magnus T, Panzer U, Stahl RA: Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int 83: 865-877, 2013
    • (2013) Kidney Int , vol.83 , pp. 865-877
    • Kluger, M.A.1    Zahner, G.2    Paust, H.J.3    Schaper, M.4    Magnus, T.5    Panzer, U.6    Stahl, R.A.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.